Tensi+ European Registry

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

February 27, 2025

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions
Overactive Bladder
Interventions
DEVICE

Tensi+

Tensi+ (Stimuli Technology, Boulogne Billancourt, France) is a newly released, medical transcutaneous-posterior tibial nerve stimulation (TC-pTNS) device marketed for overactive bladder (OAB) management.

Trial Locations (17)

35033

RECRUITING

CHU de Rennes, Rennes

RECRUITING

CHU de Rennes, Rennes

41125

NOT_YET_RECRUITING

Hesperia Hospital, Modena

50139

NOT_YET_RECRUITING

Azienda Ospedaliero-Universitaria Careggi, Florence

52025

NOT_YET_RECRUITING

Santa Maria la Gruccia Hospital, Montevarchi

69500

RECRUITING

HFME - Hospices Civils de Lyon, Bron

76031

RECRUITING

CHU de Rouen - Hôpital Charles Nicolle, Rouen

83100

NOT_YET_RECRUITING

Nuova Villa Esther, Avellino

00133

NOT_YET_RECRUITING

Policlinico Tor Vergata, Roma

00135

NOT_YET_RECRUITING

Casa di Cura Villa Stuart, Roma

00139

NOT_YET_RECRUITING

Villa Salaria Hospital, Roma

00189

NOT_YET_RECRUITING

Azienda Ospedaliero Universitaria Sant'Andrea, Roma

NOT_YET_RECRUITING

Azienda Ospedaliero Universitaria Sant'Andrea, Roma

00191

NOT_YET_RECRUITING

Clinica Nuova Villa Claudia, Roma

BS10 5NB

NOT_YET_RECRUITING

Bristol Urological Institute, Bristol

CB22 0QQ

NOT_YET_RECRUITING

Addenbrooke's Hospital, Cambridge University Hospital Trust, Cambridge

NW1 2BU

NOT_YET_RECRUITING

University College Hospital London, London

All Listed Sponsors
lead

Stimuli Technology

INDUSTRY